Literature DB >> 17970802

Filaggrin null alleles are not associated with hand eczema or contact allergy.

A Lerbaek1, H Bisgaard, T Agner, K Ohm Kyvik, C N A Palmer, T Menné.   

Abstract

BACKGROUND: The filaggrin protein is a key component of stratum corneum and homo- or heterozygotes for the filaggrin variant alleles R501X and 2282del4 have varying degrees of impaired skin barrier. The variant alleles have repeatedly been shown to be associated with atopic dermatitis. Any possible association with hand eczema or contact allergy are unexplored.
OBJECTIVES: To explore associations between the variant alleles, hand eczema, contact allergy and atopic dermatitis.
METHODS: In total, 183 adult individuals participated in a clinical examination of the hands, patch testing and filaggrin genotyping. Children without any evidence of atopic dermatitis from the Copenhagen Prospective Study on Asthma in Childhood (COPSAC) study were used as controls. The chi(2) test was used for comparison of allele frequencies.
RESULTS: The majority (73%) had hand eczema, 25% had contact allergy and 14% had a diagnosis of atopic dermatitis. The association between atopic dermatitis and the filaggrin variant alleles was confirmed (odds ratio 3.5, P = 0.015). Allele frequencies in individuals with hand eczema or contact allergy were not statistically significantly increased.
CONCLUSION: There is no association between the variant alleles and hand eczema or contact allergy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970802     DOI: 10.1111/j.1365-2133.2007.08252.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  [Health services research: the example of hand eczema].

Authors:  C J Apfelbacher; T L Diepgen
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

Review 2.  [Genetics of contact allergy].

Authors:  A Schnuch
Journal:  Hautarzt       Date:  2011-10       Impact factor: 0.751

Review 3.  Revisiting the Roles of Filaggrin in Atopic Dermatitis.

Authors:  Verena Moosbrugger-Martinz; Corinne Leprince; Marie-Claire Méchin; Michel Simon; Stefan Blunder; Robert Gruber; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

4.  Genetic Basis of Irritant Susceptibility in Health Care Workers.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; M Michael Barmada; Victor J Johnson; Michael L Kashon; Elma Baron; Nevin W Wilson; Bonnie Frye; Wei Wang; Kara Fluharty; Rola Gharib; Jean Meade; Dori Germolec; Michael I Luster; Susan Nedorost
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

Review 5.  [Atopic exzema in adulthood].

Authors:  J Schmitt; A Bauer; M Meurer
Journal:  Hautarzt       Date:  2008-10       Impact factor: 1.198

Review 6.  Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany.

Authors:  M Peiser; T Tralau; J Heidler; A M Api; J H E Arts; D A Basketter; J English; T L Diepgen; R C Fuhlbrigge; A A Gaspari; J D Johansen; A T Karlberg; I Kimber; J P Lepoittevin; M Liebsch; H I Maibach; S F Martin; H F Merk; T Platzek; T Rustemeyer; A Schnuch; R J Vandebriel; I R White; A Luch
Journal:  Cell Mol Life Sci       Date:  2011-10-14       Impact factor: 9.261

Review 7.  One remarkable molecule: filaggrin.

Authors:  Sara J Brown; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

8.  Hyperkeratotic hand eczema: Eczema or not?

Authors:  Klaziena Politiek; Laura Loman; Hendri H Pas; Gilles F H Diercks; Henny H Lemmink; Sabrina Z Jan; Peter C van den Akker; Maria C Bolling; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2020-06-01       Impact factor: 6.600

9.  Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology.

Authors:  Angelique N Voorberg; Hanna Niehues; Jart A F Oosterhaven; Geertruida L E Romeijn; Ivonne M J J van Vlijmen-Willems; Piet E J van Erp; Thomas H A Ederveen; Patrick L J M Zeeuwen; Marie L A Schuttelaar
Journal:  Exp Dermatol       Date:  2021-07-21       Impact factor: 3.960

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.